935106861
info@markelab.com
Precio
412.5€ (100 µg)
Belantamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFRSF17/CD269, Belantamab mafodotin (GSK2857916) is an antibody-conjugated drug that connects humanized anti-BCMA antibody with a cytotoxic agent. By targeting BCMA, the cytotoxic agent is specifically delivered into MM cells to kill cancer cells. effect.
Biosimilars
Human
Monoclonal
Human
TNFRSF17/CD269
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2061894-48-0
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más